| 1 |
Recent advances in precision oncology research |
|
| | Ann M. Bode,Zigang Dong | | | npj Precision Oncology. 2018; 2(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
The US Food and Drug Administration’s expedited approval programs: Addressing premarket flexibility with enhanced postmarket evidence generation |
|
| | Joshua D Wallach,Joseph S Ross,Huseyin Naci | | | Clinical Trials. 2018; 15(3): 243 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
“Fast Track” Development and Approval Process for Heart Failure Therapeutics |
|
| | L Papadimitriou,J Butler | | | Clinical Pharmacology & Therapeutics. 2017; | | | [Pubmed] [Google Scholar] [DOI] | |
|
